Ha Jang Woo, Kwon Oh Chan, Park Yong-Beom, Lee Sang-Won
Division of Rheumatology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
Division of Rheumatology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Front Med (Lausanne). 2025 Aug 6;12:1582892. doi: 10.3389/fmed.2025.1582892. eCollection 2025.
This study aimed to investigate whether a new formula consisting of more than two antineutrophil cytoplasmic antibody-associated vasculitis (AAV)-specific indices at diagnosis could predict poor outcomes during follow-up in patients with AAV.
This study included 323 patients first diagnosed with AAV. AAV-specific indices included the Birmingham vasculitis activity score (BVAS), the five-factor score (FFS), and the earliest vasculitis damage index (eVDI). Poor outcomes included all-cause mortality, end-stage kidney disease (ESKD), cerebrovascular accident (CVA), and acute coronary syndrome (ACS). The four formulas were created by adding each index: BVAS + FFS + eVDI, BVAS + FFS, BVAS + eVDI, and FFS + eVDI.
The median age was 61.0 years (36.2% men). Among the four formulas, FFS + eVDI at AAV diagnosis exhibited the highest area under the curves (AUCs) for all-cause mortality and ESKD in receiver operating characteristic curve analysis. When the optimal cut-off was determined as 4.5 for all-cause mortality and ESKD simultaneously, patients with FFS + eVDI ≥4.5 at AAV diagnosis exhibited significantly higher risks for both all-cause mortality and ESKD, and lower cumulative patients' and ESKD-free survival rates than those without. in multivariable Cox analyses with other variables at AAV diagnosis, FFS + eVDI at AAV diagnosis was proven to be an independent predictor for all-cause mortality and ESKD during follow-up in patients with AAV.
This study demonstrated that a new formula consisting of FFS and eVDI at AAV diagnosis could effectively predict both all-cause mortality and ESKD during follow-up in patients with AAV.
本研究旨在调查一种由诊断时两种以上抗中性粒细胞胞浆抗体相关血管炎(AAV)特异性指标组成的新公式是否能预测AAV患者随访期间的不良结局。
本研究纳入了323例初诊为AAV的患者。AAV特异性指标包括伯明翰血管炎活动评分(BVAS)、五因素评分(FFS)和最早血管炎损伤指数(eVDI)。不良结局包括全因死亡率、终末期肾病(ESKD)、脑血管意外(CVA)和急性冠状动脉综合征(ACS)。通过添加每个指标创建了四个公式:BVAS + FFS + eVDI、BVAS + FFS、BVAS + eVDI和FFS + eVDI。
中位年龄为61.0岁(男性占36.2%)。在四个公式中,AAV诊断时的FFS + eVDI在接受者操作特征曲线分析中对全因死亡率和ESKD的曲线下面积(AUC)最高。当全因死亡率和ESKD的最佳截断值同时确定为4.5时,AAV诊断时FFS + eVDI≥4.5的患者全因死亡率和ESKD的风险显著更高,累积患者生存率和无ESKD生存率低于未达到该截断值的患者。在对AAV诊断时的其他变量进行多变量Cox分析时,AAV诊断时的FFS + eVDI被证明是AAV患者随访期间全因死亡率和ESKD的独立预测因素。
本研究表明,AAV诊断时由FFS和eVDI组成的新公式可有效预测AAV患者随访期间的全因死亡率和ESKD。